|
Name |
2-Methyl-4-(2,6,6-trimethyl-1-cyclohexenyl)-2-butene-1-ol
|
| Molecular Formula | C14H24O | |
| IUPAC Name* |
(E)-2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-ol
|
|
| SMILES |
CC1=C(C(CCC1)(C)C)C/C=C(\C)/CO
|
|
| InChI |
InChI=1S/C14H24O/c1-11(10-15)7-8-13-12(2)6-5-9-14(13,3)4/h7,15H,5-6,8-10H2,1-4H3/b11-7+
|
|
| InChIKey |
WQRBKVJYXWPIHN-YRNVUSSQSA-N
|
|
| Synonyms |
2-Methyl-4-(2,6,6-trimethylcyclohex-1-enyl)but-2-en-1-ol; SCHEMBL9267378; SCHEMBL9267380; 2-Methyl-4-(2,6,6-trimethyl-1-cyclohexenyl)-2-butene-1-ol; (2E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenol; (E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenol; (2E)-2-Methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-ol #
|
|
| CAS | NA | |
| PubChem CID | 5369482 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 208.34 | ALogp: | 3.5 |
| HBD: | 1 | HBA: | 1 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
| Heavy Atoms: | 15 | QED Weighted: | 0.677 |
| Caco-2 Permeability: | -4.487 | MDCK Permeability: | 0.00001890 |
| Pgp-inhibitor: | 0.248 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.732 |
| 30% Bioavailability (F30%): | 0.006 |
| Blood-Brain-Barrier Penetration (BBB): | 0.958 | Plasma Protein Binding (PPB): | 93.61% |
| Volume Distribution (VD): | 3.111 | Fu: | 3.47% |
| CYP1A2-inhibitor: | 0.408 | CYP1A2-substrate: | 0.438 |
| CYP2C19-inhibitor: | 0.203 | CYP2C19-substrate: | 0.609 |
| CYP2C9-inhibitor: | 0.092 | CYP2C9-substrate: | 0.667 |
| CYP2D6-inhibitor: | 0.206 | CYP2D6-substrate: | 0.474 |
| CYP3A4-inhibitor: | 0.053 | CYP3A4-substrate: | 0.212 |
| Clearance (CL): | 9.12 | Half-life (T1/2): | 0.509 |
| hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.03 |
| Drug-inuced Liver Injury (DILI): | 0.031 | AMES Toxicity: | 0.003 |
| Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.098 |
| Skin Sensitization: | 0.867 | Carcinogencity: | 0.036 |
| Eye Corrosion: | 0.937 | Eye Irritation: | 0.981 |
| Respiratory Toxicity: | 0.163 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001425 | ![]() |
0.453 | D0S7WX | ![]() |
0.406 | ||
| ENC000328 | ![]() |
0.438 | D02DGU | ![]() |
0.338 | ||
| ENC002414 | ![]() |
0.318 | D00DKK | ![]() |
0.338 | ||
| ENC003075 | ![]() |
0.313 | D0G3PI | ![]() |
0.338 | ||
| ENC002339 | ![]() |
0.313 | D0W6DG | ![]() |
0.225 | ||
| ENC005114 | ![]() |
0.300 | D03VFL | ![]() |
0.204 | ||
| ENC001830 | ![]() |
0.297 | D04GJN | ![]() |
0.200 | ||
| ENC005830 | ![]() |
0.292 | D0K5WS | ![]() |
0.192 | ||
| ENC002921 | ![]() |
0.288 | D0MY8N | ![]() |
0.190 | ||
| ENC002922 | ![]() |
0.275 | D0H1QY | ![]() |
0.190 | ||